Alogliptin

Category: Diabetes



Alogliptin Overview

Alogliptin (trade name Nesina and Vipidia[1][2]) is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.[3] Alogliptin does not decrease the risk of heart attack and stroke. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of hypoglycemia, and has relatively modest glucose-lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in p...

Read more Alogliptin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alogliptin

Recent Alogliptin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alogliptin
  • Tablet: 12.5mg, 25mg, 6.25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Alogliptin: (3 results)

Sorted by National Drug Code
  • 45802-087 Alogliptin 6.25 mg Oral Tablet, Film Coated by Perrigo New York Inc
  • 45802-103 Alogliptin 12.5 mg Oral Tablet, Film Coated by Perrigo New York Inc
  • 45802-150 Alogliptin 25 mg Oral Tablet, Film Coated by Perrigo New York Inc

Other drugs which contain Alogliptin or a similar ingredient: (5 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA